ImmunoGen, Inc.·4

Jul 2, 8:39 AM ET

Berkenblit Anna 4

4 · ImmunoGen, Inc. · Filed Jul 2, 2020

Insider Transaction Report

Form 4
Period: 2020-06-30
Berkenblit Anna
VP & Chief Medical Officer
Transactions
  • Award

    Common Stock

    2020-06-30$3.91/sh+3,047$11,914101,136 total
Footnotes (2)
  • [F1]These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from January 1, 2020 through June 30, 2020.
  • [F2]In accordance with the ESPP; these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2020.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -